Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 52Unknown 19Terminated 9Recruiting 3Not yet recruiting 3Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Stomatitis 1Papillomavirus Infections 1Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX 1Mucositis 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Folic Acid × Clear all
NCT03581773 2026-05-04

DARENCA4

University of Aarhus

Phase 2 Recruiting
100 enrolled
Other

Stomatitis, Mucositis

NCT06285357 2025-11-20

The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.

Lo.Li.Pharma s.r.l

Phase NA Recruiting
100 enrolled

Papillomavirus Infections

NCT05378919 2022-05-18

RECTUM2015

Lithuanian University of Health Sciences

Phase 2 Recruiting
250 enrolled
Gastrointestinal

Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX

Data powered by HemOnc (CC BY 4.0) Colophon âš¡